The lansoprazole and albendazole treatments can be a potential drug or combined with antidiabetic drugs in T2D treatment byAdenosine 5′-monophosphate activated protein kinase (AMPK), peroxisome proliferator-activated receptor (PPAR),incretin-like effectand other antidiabetic mechanisms. The gene discussed is PPARA; the disease is type 2 diabetes mellitus.